Status:
COMPLETED
Curcumin Supplementation for the Improvement of Diabetes-related Outcomes
Lead Sponsor:
Oklahoma State University
Conditions:
Over Age 60
Prediabetes or Overweight
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn about, test, and compare health outcomes of curcumin supplementation (400 mg). Two primary hypotheses are: 1. Curcumin supplementation will improve glycemi...
Eligibility Criteria
Inclusion
- To be eligible, participants were required to meet at least one of the following criteria: a) Prediabetes, defined as a fasting blood glucose level of 100-125 mg/dL or an HbA1c of 5.7-6.4%, or b) A body mass index (BMI) ≥25.
Exclusion
- a) A preexisting cardiometabolic condition such as diabetes, b) Liver disease, c) De-mentia, d) Tobacco use within one year prior to the study, and e) Use of medications targeting diabetes or blood lipids.
Key Trial Info
Start Date :
March 16 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 13 2025
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT06984640
Start Date
March 16 2023
End Date
February 13 2025
Last Update
May 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratory for Applied Nutrition and Exercise Science (LANES)
Stillwater, Oklahoma, United States, 74078